Categories: Health

Stryker to host investor day

 | Source: Stryker Corporation

Portage, Michigan, Aug. 15, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that it will host an Investor Day on Thursday, November 13, 2025, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey.

A live audio webcast of the session, along with a replay, will be accessible on Stryker’s official website at www.stryker.com. The recording will be archived on the Investor Relations section of the site.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com 

For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com

GlobeNews Wire

Recent Posts

/C O R R E C T I O N — Trigent Software/

In the news release, Trigent and Codec Partner to Launch Global Capability Centres in Bengaluru…

1 hour ago

KuCoin Launches Stock Index Perpetual Contracts, Expanding 24/7 Cross-Asset Access

PROVIDENCIALES, Turks and Caicos Islands, March 13, 2026 /PRNewswire/ -- KuCoin, a leading global crypto…

1 hour ago

InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company…

3 hours ago

Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization

Lead investor confirmed his intention to maintain his current shareholdings.Company does not anticipate using more…

3 hours ago

Novartis Cosentyx receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa

Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism…

3 hours ago

Microvast Schedules Fourth Quarter Earnings Call

March 13, 2026 15:00 ET  | Source: Microvast Holdings, Inc. STAFFORD, Texas, March 13, 2026…

5 hours ago